<?xml version="1.0" encoding="UTF-8"?>
<compound>
  <id type="integer">345531</id>
  <title nil="true"/>
  <common-name>[(2s,3s,5s,10s,13s)-10,13-dimethyl-2-(1-methylpyrrolidin-1-ium-1-yl)-17-oxo-1,2,3,4,5,6,7,8,9,11,12,14,15,16-tetradecahydrocyclopenta[a]phenanthren-3-yl] acetate</common-name>
  <description>[(2s,3s,5s,10s,13s)-10,13-dimethyl-2-(1-methylpyrrolidin-1-ium-1-yl)-17-oxo-1,2,3,4,5,6,7,8,9,11,12,14,15,16-tetradecahydrocyclopenta[a]phenanthren-3-yl] acetate is a compound with the formula C26H42NO3+. It has an average molecular weight of 416.60 g/mol.</description>
  <cas nil="true"/>
  <pubchem-id>3038044</pubchem-id>
  <chemical-formula>C26H42NO3+</chemical-formula>
  <weight>416.6</weight>
  <appearance nil="true"/>
  <melting-point nil="true"/>
  <boiling-point nil="true"/>
  <density nil="true"/>
  <solubility nil="true"/>
  <specific-gravity nil="true"/>
  <flash-point nil="true"/>
  <vapour-pressure nil="true"/>
  <route-of-exposure nil="true"/>
  <target nil="true"/>
  <mechanism-of-toxicity nil="true"/>
  <metabolism nil="true"/>
  <toxicity nil="true"/>
  <lethaldose nil="true"/>
  <carcinogenicity nil="true"/>
  <use-source nil="true"/>
  <min-risk-level nil="true"/>
  <health-effects nil="true"/>
  <symptoms nil="true"/>
  <treatment nil="true"/>
  <created-at type="dateTime">2026-08-31T08:22:56Z</created-at>
  <updated-at type="dateTime">2026-08-31T08:22:56Z</updated-at>
  <interacting-proteins nil="true"/>
  <wikipedia nil="true"/>
  <uniprot-id nil="true"/>
  <kegg-compound-id nil="true"/>
  <omim-id nil="true"/>
  <chebi-id nil="true"/>
  <biocyc-id nil="true"/>
  <ctd-id nil="true"/>
  <stitch-id nil="true"/>
  <drugbank-id nil="true"/>
  <pdb-id nil="true"/>
  <actor-id nil="true"/>
  <organism nil="true"/>
  <export type="boolean">true</export>
  <metabolizing-proteins nil="true"/>
  <transporting-proteins nil="true"/>
  <moldb-smiles>CC(=O)OC1CC2CCC3C4CCC(=O)C4(CCC3C2(CC1[N+]5(CCCC5)C)C)C</moldb-smiles>
  <moldb-formula>C26H42NO3+</moldb-formula>
  <moldb-inchi>InChI=1S/C26H42NO3/c1-17(28)30-23-15-18-7-8-19-20-9-10-24(29)25(20,2)12-11-21(19)26(18,3)16-22(23)27(4)13-5-6-14-27/h18-23H,5-16H2,1-4H3/q+1/t18-,19?,20?,21?,22-,23-,25-,26-/m0/s1</moldb-inchi>
  <moldb-inchikey>JHIZNZPCYRQMLI-FLGLGBLRSA-N</moldb-inchikey>
  <moldb-average-mass type="decimal" nil="true"/>
  <moldb-mono-mass type="decimal">416.3164692</moldb-mono-mass>
  <origin nil="true"/>
  <state nil="true"/>
  <logp>4.5</logp>
  <hmdb-id nil="true"/>
  <chembl-id nil="true"/>
  <chemspider-id nil="true"/>
  <structure-image-file-name nil="true"/>
  <structure-image-content-type nil="true"/>
  <structure-image-file-size type="integer" nil="true"/>
  <structure-image-updated-at type="dateTime" nil="true"/>
  <biodb-id nil="true"/>
  <synthesis-reference nil="true"/>
  <structure-image-caption nil="true"/>
  <chemdb-id>CHEM341424</chemdb-id>
  <dsstox-id nil="true"/>
  <toxcast-id nil="true"/>
  <stoff-ident-origin nil="true"/>
  <stoff-ident-id nil="true"/>
  <susdat-id nil="true"/>
  <iupac>[(2s,3s,5s,10s,13s)-10,13-dimethyl-2-(1-methylpyrrolidin-1-ium-1-yl)-17-oxo-1,2,3,4,5,6,7,8,9,11,12,14,15,16-tetradecahydrocyclopenta[a]phenanthren-3-yl] acetate</iupac>
  <moldb-polar-surface-area nil="true"/>
  <moldb-refractivity nil="true"/>
  <moldb-polarizability nil="true"/>
  <moldb-rotatable-bond-count nil="true"/>
  <moldb-acceptor-count nil="true"/>
  <moldb-donor-count nil="true"/>
  <moldb-pka-strongest-acidic nil="true"/>
  <moldb-pka-strongest-basic nil="true"/>
  <moldb-physiological-charge nil="true"/>
  <moldb-number-of-rings nil="true"/>
  <moldb-alogps-logp nil="true"/>
  <moldb-alogps-logs nil="true"/>
  <moldb-alogps-solubility nil="true"/>
  <kingdom>Organic compounds</kingdom>
  <superklass>Lipids and lipid-like molecules</superklass>
  <klass>Steroids and steroid derivatives</klass>
  <subklass>Steroid esters</subklass>
  <paper-count type="integer" nil="true"/>
  <sync-id>CED0295888</sync-id>
  <structure-inchikey>JHIZNZPCYRQMLI-UHFFFAOYSA-N</structure-inchikey>
  <structure-fingerprint>10000000000000400000000004000400000000000000010000000000001000000000000000000200000000000000000000000000020000000000000000000100160c0000000000000000000000200000020000001000100000000000000020000000002010000000000000000000000000000020000000000000000000000500810000048000000010000000200000000200000000000000000000000000020000800000004000048000000080000000000000000000020040008000000000000000000000000010000000200020080000000020000000000204000000000000001000000000001000000080000000500000000000000080000000000000000</structure-fingerprint>
  <structure-pattern-fingerprint>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</structure-pattern-fingerprint>
  <structure-pickle type="binary" encoding="base64">776t3gAAAAAQAAAAAwAAAAAAAAAeAAAAIgAAAIABBgBgAAAAAQMGACgAAAAD
BAgAKAAAAAMCCAAoAAAAAwIGAGAAAAADAQYAYAAAAAICBgBgAAAAAwEGAGAA
AAACAgYAYAAAAAICBgBgAAAAAwEGAGAAAAADAQYAYAAAAAICBgBgAAAAAgIG
ACgAAAADBAgAKAAAAAMCBgAgAAAABAYAYAAAAAICBgBgAAAAAgIGAGAAAAAD
AQYAIAAAAAQGAGAAAAACAgYAYAAAAAMBByAiAAAAAQQGAGAAAAACAgYAYAAA
AAICBgBgAAAAAgIGAGAAAAACAgYAYAAAAAEDBgBgAAAAAQMGAGAAAAABAwsA
AQABAigCAQMgAwQABAUABQYABgcABwgACAkACQoACgsACwwADA0ADQ4IAg0P
AA8QABARABESABITABMUABQVABUWABYXABcYABgZABkaABYbABMcAA8dABUE
ABMGABIJAA8KABoWAEIFAAAABgQVFBMGBQYHCAkSEwYFCwoPDQwGEBESCQoP
BRcWGhkYFwQAAAAAAAAAFg==
</structure-pickle>
  <structure-indexed-at type="dateTime">2026-09-19T05:44:33Z</structure-indexed-at>
</compound>
